While in our studies Spry4 wildtype protein failed to influence the activity of MAPK in WI-38 cells as well as in osteosarcoma-derived cells in response to FGF2 induction, the conversion of the serine at position 241 empowered the protein to interfere with FGF-mediated signal transduction. This evidence concerns the gene SPRY4 and osteosarcoma.